Canterbury Health Research Conference Friday Venue: Christchurch School of Medicine & Health Sciences, Riccarton Ave Saturday venue: Chateau on the Park, 189 Deans Ave Preliminary Program Day One: Friday 26 August, Christchurch School of Medicine & Health Sciences Time Event Location Details "Corticotropin releasing factor (CRF) & urocortin receptors: roles in stress and beyond" Day Two: Saturday 27 August, Chateau on the Park
Gene and protein expression changes induced by chronic exposure to the antidepressant paroxetine
1 (Joint)
Adrenomedullin increases cardiac sympathetic nerve activity in normal conscious sheep
Object working memory deficits predicted by early brain injury and development in the preterm infant
Clinical and neurobehavioural outcomes of infants exposed to methadone during pregnancy
Psychosocial and health profiles of pregnant women maintained on methadone: research issues and findings
Predictors of maternal stress in the neonatal intensive care unit
2a (Parallel)
Coordinating respiration and nutritive swallowing in the first year of life
Amino-terminal proCNP: a putative marker of growthplate activity in post natal growth
Glial activation precedes neurodegeration in ovine Batten disease, begins during prenatal brain development, and
spreads from specific foci associated with later symptoms
Association of angiotensinogen M235T and T174M gene polymorphisms with mortality in heart failure
Genetic polymorphisms as predictors of clinical outcome after acute myocardial infarction
2b (Parallel)
The Christchurch tissue bank: a biorepository for cancer research
Role of NADPH oxidase - derived oxidants in neutrophil apoptosis
Effects of ageing on liver sinusoid caveolin-1 expression
Analysis of cells by atomic force microscopy
Changes in gene expression and the role of the natriuretic peptides in cardiac development
Ventricular gene expression changes during the development of cardiac hypertrophy in Npr-1 knockout mice
3a (Parallel)
Pitch and loudness effect on the electroglottographic measures in voice patients
Outcomes of Christchurch early intervention for psychosis service
A neurorehabilitation tool for off-road assessment of driving ability in subjects with brain disorders
Model-based assessment of insulin resistance in broad populations
Clinical trials of active and adaptive insulin and nutrition control to control hyperglycaemia in critically ill patients
3b (Parallel)
Modelling stochastic insulin sensitivity variability in critical care
The responses of luteinising hormone to interacting peptides: A mathematical model
Cyclosporin monitoring in kidney transplantation: is c2 really superior?
Vitamin D analogues for the treatment of bone disease outcomes in chronic kidney disease: a systematic review
The prevalence and genetic determinants of inflammatory bowel disease in Canterbury
4 (Joint)
Stability and instability in alcohol diagnoses in late adolescence and early adulthood
Using gene therapy to activate paracetamol for anti-vascular treatment of cancer
Vitamin C is essential for neutrophil apoptosis. Implications for the resolution of inflammation and death by scurvy
1600-1700 Closing remarks, drinks, prize giving
Diagnosis follows dropped cowardice charge Anti-malarial drug is cited as possible cause of soldier’s illness By Laura Bailey An Army interrogator sent home from Iraq and charged with cowardice last October is one of 11 service members who have been diagnosed with a balance disorder a Navy doctor says may be caused by Lariam, the anti-malarial drug given to deploying service members
DM45624.qxp:DM45624 Meds 11/16/09 1:57 PM Page 1 Anticholinergic Agents COMBINATION BRONCHODILATOR THERAPY The key mechanism of anticholinergic medicationsappears to be the blocking of muscarinic receptors(M1, M2, and M3). By blocking acetylcholine-• Combining bronchodilators with differentmediated bronchoconstriction, the end resultSide effects associated with anticholinergic therapyâ